Zobrazeno 1 - 10
of 367
pro vyhledávání: '"Nicolazzi C"'
Autor:
Lefebvre AM; Sanofi Research and Development, Sanofi, Chilly-Mazarin, France., Adam J; International Thoracic Cancer Center, Inserm U1186, Gustave Roussy, Villejuif, France., Nicolazzi C; Sanofi Research and Development, Sanofi, Vitry-sur-Seine, France., Larois C; Sanofi Research and Development, Sanofi, Vitry-sur-Seine, France., Attenot F; Sanofi Research and Development, Sanofi, Vitry-sur-Seine, France., Falda-Buscaiot F; Sanofi Research and Development, Sanofi, Vitry-sur-Seine, France., Dib C; Sanofi Research and Development, Sanofi, Vitry-sur-Seine, France., Masson N; IT&M Stats on behalf of Sanofi, Neuilly-sur-Seine, France., Ternès N; Sanofi Research and Development, Sanofi, Chilly-Mazarin, France., Bauchet AL; Sanofi Research and Development, Sanofi, Chilly-Mazarin, France., Demers B; Sanofi Research and Development, Sanofi, Vitry-sur-Seine, France., Chadjaa M; Sanofi Research and Development, Sanofi, Vitry-sur-Seine, France., Sidhu S; Sanofi Research and Development, Sanofi, Vitry-sur-Seine, France., Combeau C; Sanofi Research and Development, Sanofi, Chilly-Mazarin, France., Soria JC; Jean-Charles Soria, Director General, Gustave Roussy, Villejuif, France., Scoazec JY; Department of Pathology and Laboratory Medicine, Gustave Roussy, Villejuif , France; Faculté de Médecine de Bicêtre, Université Paris-Saclay, Le Kremlin-Bicêtre, France., Naimi S; Sanofi Research and Development, Sanofi, Chilly-Mazarin, France., Angevin E; Faculté de Médecine de Bicêtre, Université Paris-Saclay, Le Kremlin-Bicêtre, France; Drug Development Department (DITEP) and Clinical Research Division, Gustave Roussy, Villejuif, France., Chiron M; Sanofi Research and Development, Sanofi, Vitry-sur-Seine, France., Henry C; Sanofi Research and Development, Sanofi, Vitry-sur-Seine, France. Electronic address: christophe.henry@sanofi.com.
Publikováno v:
Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2023 Oct; Vol. 184, pp. 107356. Date of Electronic Publication: 2023 Aug 26.
Autor:
Gauthier L; Innate Pharma, Marseille, France. laurent.gauthier@innate-pharma.fr., Virone-Oddos A; Sanofi Immuno-Oncology Research, Vitry sur-Seine, France. Angela.Virone-Oddos@sanofi.com., Beninga J; Sanofi Large Molecules Research, Frankfurt, Germany., Rossi B; Innate Pharma, Marseille, France., Nicolazzi C; Sanofi Immuno-Oncology Research, Vitry sur-Seine, France., Amara C; Sanofi Drug Metabolism and Pharmacokinetics, Chilly Mazarin, France., Blanchard-Alvarez A; Innate Pharma, Marseille, France., Gourdin N; Innate Pharma, Marseille, France., Courta J; Sanofi TMED Biomarkers and Clinical Bioanalysis, Chilly Mazarin, France., Basset A; Sanofi Preclinical Safety, Chilly Mazarin, France., Agnel M; Sanofi Global Project Management, Vitry sur-Seine, France., Guillot F; Innate Pharma, Marseille, France., Grondin G; Innate Pharma, Marseille, France., Bonnevaux H; Sanofi Immuno-Oncology Research, Vitry sur-Seine, France., Bauchet AL; Sanofi Global Project Management, Vitry sur-Seine, France., Morel A; Innate Pharma, Marseille, France., Morel Y; Innate Pharma, Marseille, France., Chiron M; Sanofi Immuno-Oncology Research, Vitry sur-Seine, France., Vivier E; Innate Pharma, Marseille, France. eric.vivier@innate-pharma.fr.; Aix-Marseille University, Centre of National Scientific Research (CNRS), National Insititute of Health and Medical Research (INSERM), Centre of Immunology at Marseille-Luminy (CIML), Marseille, France. eric.vivier@innate-pharma.fr.; APHM, Marseille-Immunopole, University Hospital of Timone, Marseille, France. eric.vivier@innate-pharma.fr.
Publikováno v:
Nature biotechnology [Nat Biotechnol] 2023 Sep; Vol. 41 (9), pp. 1296-1306. Date of Electronic Publication: 2023 Jan 12.
Autor:
Decary S; Sanofi R&D, Vitry-sur-Seine, France. stephanie.decary@sanofi.com., Berne PF; Sanofi R&D, Vitry-sur-Seine, France., Nicolazzi C; Sanofi R&D, Vitry-sur-Seine, France., Lefebvre AM; Sanofi R&D, Vitry-sur-Seine, France., Dabdoubi T; Sanofi R&D, Vitry-sur-Seine, France., Cameron B; Sanofi R&D, Vitry-sur-Seine, France., Rival P; Sanofi R&D, Vitry-sur-Seine, France., Devaud C; Sanofi R&D, Vitry-sur-Seine, France., Prades C; Sanofi R&D, Vitry-sur-Seine, France., Bouchard H; Sanofi R&D, Vitry-sur-Seine, France., Cassé A; Sanofi R&D, Vitry-sur-Seine, France., Henry C; Sanofi R&D, Vitry-sur-Seine, France., Amara C; Sanofi R&D, Vitry-sur-Seine, France., Brillac C; Sanofi R&D, Vitry-sur-Seine, France., Ferrari P; Sanofi R&D, Vitry-sur-Seine, France., Maçon L; Sanofi R&D, Vitry-sur-Seine, France., Lacoste E; Sanofi R&D, Vitry-sur-Seine, France., Combeau C; Sanofi R&D, Vitry-sur-Seine, France., Beys E; Sanofi R&D, Vitry-sur-Seine, France., Naimi S; Sanofi R&D, Vitry-sur-Seine, France., García-Echeverría C; Sanofi R&D, Vitry-sur-Seine, France., Mayaux JF; Sanofi R&D, Vitry-sur-Seine, France., Blanc V; Sanofi R&D, Vitry-sur-Seine, France.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Dec 15; Vol. 26 (24), pp. 6589-6599. Date of Electronic Publication: 2020 Oct 12.
Autor:
Kassem S; Cancer Research Center of Toulouse (CRCT), Institut National de la Santé et de la Recherche Médicale (INSERM) Unité Mixte de Recherche (UMR) 1037, Centre National de la Recherche Scientifique (CNR S), Université Paul Sabatier (UPS), Toulouse, France., Diallo BK; Sanofi Oncology Research, Vitry-sur-Seine, France.; Cancer, Immune Control and Escape' Laboratory, Centre de Recherche des Cordeliers, Sorbonne Université, Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot, INSERM UMR 1138, Paris, France.; Laboratory 'Immune Microenvironment and Immunotherapy, INSERM U1135, Centre d'Immunologie et des Maladies Infectieuses Paris (CIMI-Paris), Sorbonne Université, UMR 1135, Faculté de Médecine Sorbonne Université, Paris, France., El-Murr N; Sanofi Oncology Research, Vitry-sur-Seine, France., Carrié N; Cancer Research Center of Toulouse (CRCT), Institut National de la Santé et de la Recherche Médicale (INSERM) Unité Mixte de Recherche (UMR) 1037, Centre National de la Recherche Scientifique (CNR S), Université Paul Sabatier (UPS), Toulouse, France., Tang A; Sanofi Oncology Research, Vitry-sur-Seine, France., Fournier A; Sanofi Oncology Research, Vitry-sur-Seine, France., Bonnevaux H; Sanofi Oncology Research, Vitry-sur-Seine, France., Nicolazzi C; Sanofi Oncology Research, Vitry-sur-Seine, France., Cuisinier M; Cancer Research Center of Toulouse (CRCT), Institut National de la Santé et de la Recherche Médicale (INSERM) Unité Mixte de Recherche (UMR) 1037, Centre National de la Recherche Scientifique (CNR S), Université Paul Sabatier (UPS), Toulouse, France.; Institut Universitaire du Cancer, Centre Hospitalier Universitaire (CHU) Toulouse, Toulouse, France., Arnould I; Sanofi Biologics Research, Vitry-sur-Seine, France., Sidhu SS; Sanofi Oncology Research, Vitry-sur-Seine, France., Corre J; Cancer Research Center of Toulouse (CRCT), Institut National de la Santé et de la Recherche Médicale (INSERM) Unité Mixte de Recherche (UMR) 1037, Centre National de la Recherche Scientifique (CNR S), Université Paul Sabatier (UPS), Toulouse, France.; Institut Universitaire du Cancer, Centre Hospitalier Universitaire (CHU) Toulouse, Toulouse, France., Avet-Loiseau H; Cancer Research Center of Toulouse (CRCT), Institut National de la Santé et de la Recherche Médicale (INSERM) Unité Mixte de Recherche (UMR) 1037, Centre National de la Recherche Scientifique (CNR S), Université Paul Sabatier (UPS), Toulouse, France.; Institut Universitaire du Cancer, Centre Hospitalier Universitaire (CHU) Toulouse, Toulouse, France., Teillaud JL; Cancer, Immune Control and Escape' Laboratory, Centre de Recherche des Cordeliers, Sorbonne Université, Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot, INSERM UMR 1138, Paris, France.; Laboratory 'Immune Microenvironment and Immunotherapy, INSERM U1135, Centre d'Immunologie et des Maladies Infectieuses Paris (CIMI-Paris), Sorbonne Université, UMR 1135, Faculté de Médecine Sorbonne Université, Paris, France., van de Velde H; Sanofi Oncology Development, Cambridge, MA; and., Wiederschain D; Sanofi Oncology Research, Cambridge, MA., Chiron M; Sanofi Oncology Research, Vitry-sur-Seine, France., Martinet L; Cancer Research Center of Toulouse (CRCT), Institut National de la Santé et de la Recherche Médicale (INSERM) Unité Mixte de Recherche (UMR) 1037, Centre National de la Recherche Scientifique (CNR S), Université Paul Sabatier (UPS), Toulouse, France.; Institut Universitaire du Cancer, Centre Hospitalier Universitaire (CHU) Toulouse, Toulouse, France., Virone-Oddos A; Sanofi Oncology Research, Vitry-sur-Seine, France.
Publikováno v:
Blood [Blood] 2022 Feb 24; Vol. 139 (8), pp. 1160-1176.
Autor:
Adam, J., Lefebvre, A-M., Nicolazzi, C., Larois, C., Attenot, F., Falda-Buscaiot, F., Dib, C., Ternès, N., Masson, N., Bauchet, A-L., Demers, B., Chadjaa, M., Sidhu, S., Combeau, C., Soria, J-C., Scoazec, J-Y., Naimi, S., Angevin, E., Chiron, M., Henry, C.
Publikováno v:
In Annals of Oncology December 2021 32 Supplement 7:S1381-S1381
Autor:
Wang A; Sanofi Immuno-Oncology, Cambridge, Massachusetts., Song Z; Sanofi Immuno-Oncology, Cambridge, Massachusetts., Zheng G; Sanofi Immuno-Oncology, Cambridge, Massachusetts., Nicolazzi C; Sanofi Immuno-Oncology, Vitry-Sur-Seine, France., Fromm JR; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington., Shehu E; Sanofi Immuno-Oncology, Cambridge, Massachusetts., Srinivasan S; Sanofi Immuno-Oncology, Cambridge, Massachusetts., Chen X; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington., Zhu C; Sanofi Immuno-Oncology, Cambridge, Massachusetts. chen.zhu@sanofi.com., Blondel MC; Sanofi Immuno-Oncology, Vitry-Sur-Seine, France., Adrian FJ; Sanofi Immuno-Oncology, Cambridge, Massachusetts.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2021 Oct; Vol. 20 (10), pp. 1916-1925. Date of Electronic Publication: 2021 Aug 10.
Autor:
Testa, Ugo1 (AUTHOR) germana.castelli@iss.it, Castelli, Germana1 (AUTHOR), Pelosi, Elvira1 (AUTHOR)
Publikováno v:
Cancers. Nov2024, Vol. 16 Issue 21, p3627. 29p.
Autor:
Nicolazzi C; Sanofi R&D, Vitry-sur-Seine, France. celine.nicolazzi@sanofi.com., Caron A; Sanofi R&D, Vitry-sur-Seine, France., Tellier A; Sanofi R&D, Vitry-sur-Seine, France., Trombe M; Sanofi R&D, Vitry-sur-Seine, France., Pinkas J; ImmunoGen Inc., Waltham, Massachusetts., Payne G; ImmunoGen Inc., Waltham, Massachusetts., Carrez C; Sanofi R&D, Vitry-sur-Seine, France., Guérif S; Sanofi R&D, Vitry-sur-Seine, France., Maguin M; Sanofi R&D, Vitry-sur-Seine, France., Baffa R; Sanofi R&D, Cambridge, Massachusetts., Fassan M; University of Padua, Padova, Italy., Adam J; Gustave Roussy, Villejuif, France., Mangatal-Wade L; Sanofi R&D, Vitry-sur-Seine, France., Blanc V; Sanofi R&D, Vitry-sur-Seine, France.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2020 Aug; Vol. 19 (8), pp. 1660-1669. Date of Electronic Publication: 2020 May 25.
Autor:
Yu, Yao‐An1,2 (AUTHOR), Lien, Wan‐Ju1 (AUTHOR), Lin, Wen‐Ching1 (AUTHOR), Pan, Yi‐Chung1 (AUTHOR), Huang, Sin‐Wei1 (AUTHOR), Mou, Chung‐Yuan3 (AUTHOR), Hu, Che‐Ming Jack1,2,4 (AUTHOR) chu@ibms.sinica.edu.tw, Mou, Kurt Yun1 (AUTHOR)
Publikováno v:
Advanced Science. 9/4/2024, Vol. 11 Issue 33, p1-16. 16p.
Autor:
Mosna, Federico1 (AUTHOR) federico.mosna@sabes.it
Publikováno v:
Cancers. Jul2024, Vol. 16 Issue 13, p2359. 29p.